Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer

INTRODUCTION: Aromatase inhibitors (AIs) are a vital component of estrogen receptor positive (ER+) breast cancer treatment. De novo and acquired resistance, however, is common. The aims of this study were to relate patterns of copy number aberrations to molecular and proliferative response to AIs, t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: López-Knowles, Elena, Wilkerson, Paul M, Ribas, Ricardo, Anderson, Helen, Mackay, Alan, Ghazoui, Zara, Rani, Aradhana, Osin, Peter, Nerurkar, Ash, Renshaw, Lorna, Larionov, Alexey, Miller, William R, Dixon, J Michael, Reis-Filho, Jorge S, Dunbier, Anita K, Martin, Lesley-Ann, Dowsett, Mitch
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4406016/
https://ncbi.nlm.nih.gov/pubmed/25888249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0532-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados